ANTHELIOS 20
LOE Approachingavobenzone; ecamsule; octocrylene; titanium dioxide
NDATOPICALCREAM
Approved
Oct 2006
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
ANTHELIOS 20 (avobenzone; ecamsule; octocrylene; titanium dioxide). Approved for sunburns, wind burned, chapped lips. First approved in 2006.
Drug data last refreshed 3h ago · AI intelligence enriched 4w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ANTHELIOS 20 is a broad-spectrum topical sunscreen cream combining four UV-protective actives (avobenzone, ecamsule, octocrylene, and titanium dioxide) to provide UVA/UVB protection. It is indicated for prevention and treatment of sunburn, wind burn, and chapped lips. The product works through physical and chemical UV absorption and reflection mechanisms.
LOE Approaching
With lifecycle at LOE approaching, the brand team is likely focused on line extensions, defensive positioning, or transition planning rather than growth expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications (3)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.